Presentation is loading. Please wait.

Presentation is loading. Please wait.

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study 

Similar presentations


Presentation on theme: "Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study "— Presentation transcript:

1 Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study  P.G. Rose, J. Java, M.A. Morgan, A.A. Secord, J. Kesterson, F.B. Stehman, D.P. Warshal, W.T. Creasman, P. Hanjani, R.T. Morris, L.J. Copeland  Gynecologic Oncology  Volume 141, Pages (June 2016) DOI: /j.ygyno Copyright © Terms and Conditions

2 Fig. 1 Kaplan-Meier Overall Survival by Residual Disease.
Gynecologic Oncology  , DOI: ( /j.ygyno ) Copyright © Terms and Conditions


Download ppt "Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival: an NRG Oncology/Gynecologic Oncology Group study "

Similar presentations


Ads by Google